Sarai Citlalic Rodríguez-Reyes

Dr. Sarai Citlalic Rodríguez-Reyes

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
Karla Paulina Luna CastilloKarla Paulina Luna Castillo
Karla Paulina Luna Castillo
Xochitl Citlalli Olivares OchoaXochitl Citlalli Olivares Ochoa
Xochitl Citlalli Olivares Ochoa
Rocío Guadalupe Hernández-RuizRocío Guadalupe Hernández-Ruiz
Rocío Guadalupe Hernández-Ruiz
ILIris Monserrat Llamas-Covarrubias
Iris Monserrat Llamas-Covarrubias
SRSarai Citlalic Rodríguez-Reyes
Sarai Citlalic Rodríguez-Reyes
Andres López-QuinteroAndres López-Quintero
Andres López-Quintero
Approximately 25–50% of the population worldwide exhibits serum triglycerides (TG) (≥150 mg/dL) which are associated with an increased level of highly atherogenic remnant-like particles, non-alcoholic fatty liver disease, and pancreatitis risk. High serum TG levels could be related to cardiovascular disease, which is the most prevalent cause of mortality in Western countries. The etiology of hypertriglyceridemia (HTG) is multifactorial and can be classified as primary and secondary causes. Among the primary causes are genetic disorders. On the other hand, secondary causes of HTG comprise lifestyle factors, medical conditions, and drugs. Among lifestyle changes, adequate diets and nutrition are the initial steps to treat and prevent serum lipid alterations. Dietary intervention for HTG is recommended in order to modify the amount of macronutrients. Macronutrient distribution changes such as fat or protein, low-carbohydrate diets, and caloric restriction seem to be effective strategies in reducing TG levels. Particularly, the Mediterranean diet is the dietary pattern with the most consistent evidence for efficacy in HTG while the use of omega-3 supplements consumption is the dietary component with the highest number of randomized clinical trials (RCT) carried out with effective results on reducing TG. The aim of this review was to provide a better comprehension between human nutrition and lipid metabolism.

12 March 2020 in Journal of Human Nutrition and Dietetics
Verified
Journal Article
Closed access
PDF file
WPWendy Yareni Campos Pérez
Wendy Yareni Campos Pérez
MRMariana Perez Robles
Mariana Perez Robles
NTNathaly Torres
Nathaly Torres
SRSarai Citlalic Rodríguez-Reyes
Sarai Citlalic Rodríguez-Reyes
LTL. F. De la Cerda Trujillo
L. F. De la Cerda Trujillo
EMErika Martinez-Lopez
Erika Martinez-Lopez

Verified
Journal Article
Open access
PDF file
JSJaime Sanchez-Meza
Jaime Sanchez-Meza
MCMarina Campos
Marina Campos
JRJosé Alfredo Domínguez Rosales
José Alfredo Domínguez Rosales
Juliana Marisol Godínez-RubíJuliana Marisol Godínez-Rubí
Juliana Marisol Godínez-Rubí
SRSarai Citlalic Rodríguez-Reyes
Sarai Citlalic Rodríguez-Reyes
LSLAURA V. SANCHEZ-OROZCO
LAURA V. SANCHEZ-OROZCO
This study aimed to analyze the biochemical, histological, and gene expression alterations produced in a hepatocarcinogenesis model induced by the chronic administration of diethylnitrosamine (DEN) and 2-acetylaminofluorene (2-AAF) in Wistar rats. Thirteen rats weighing 180 to 200 g were divided into two groups: control and treated. Rats in the treated group were administered an intraperitoneal (i.p.) injection of DEN (50 mg/kg/week) and an intragastric (i.g.) dose of 2-AAF (25 mg/kg/week) for 18 weeks. The treated group had significant increases in their total cholesterol, HDL-C, AST, ALT, ALKP, and GGT levels. Furthermore, a histological analysis showed the loss of normal liver architecture with nuclear pleomorphism in the hepatocytes, atypical mitosis, and fibrous septa that were distributed between the portal triads and collagen fibers through the hepatic sinusoids. The gene expressions of 24 genes related to fibrosis, inflammation, apoptosis, cell growth, angiogenesis, lipid metabolism, and alpha-fetoprotein (AFP) were analyzed; only TGFβ, COL1α1, CYP2E1, CAT, SOD, IL6, TNF-α, and ALB showed significant differences when both groups were compared. Additionally, lung histopathological alterations were found in the treated group, suggesting metastasis. In this model, the chronic administration of DEN+2-AAF induces characteristic alterations of hepatocellular carcinoma in Wistar rats without AFP gene expression changes, highlighting different signatures in hepatocellular carcinoma heterogeneity.

8 January 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
JTJoel Torres-Vanegas
Joel Torres-Vanegas
RRRoberto Rodriguez-Echevarria
Roberto Rodriguez-Echevarria
WPWendy Yareni Campos Pérez
Wendy Yareni Campos Pérez
SRSarai Citlalic Rodríguez-Reyes
Sarai Citlalic Rodríguez-Reyes
SRSamantha Desireé Reyes-Pérez
Samantha Desireé Reyes-Pérez
EMErika Martinez-Lopez
Erika Martinez-Lopez
Background/Objectives: Obesity is associated with chronic low-grade inflammation. Polyunsaturated fatty acids (PUFAs) such as omega-3 (n-3), are essential in anti-inflammatory processes. Therefore, the aim of this study was to evaluate the effect of a dietary intervention along with supplementation of 1.8 g of marine n-3 PUFAs on anthropometric, biochemical, and inflammatory markers in adults. Methods: An 8-week double-blind randomized clinical trial was conducted with a diet (200 kcal/day reduction each 4 weeks based on the estimated basal caloric expenditure) containing a n-6/n-3 PUFA ratio ≤ 5:1, along with daily 1.8 g of marine n-3 supplementation (EPA and DHA) vs. active placebo 1.6 g (ALA). A total of 40 subjects were included in the study, 21 in the marine omega-3 group and 19 in the active placebo group. Inclusion criteria included subjects aged 25 to 50 years with obesity as determined by body mass index (BMI) and/or abdominal obesity according to ATP III criteria. Results: The marine omega-3 supplemented group had a better effect compared to the active placebo group, increasing Resolvin D1 [129.3 (−90.1–193.5) vs. −16.8 (−237.8–92.5) pg/mL, p = 0.041], IL-10 [1.4 (−0.7–4.6) vs. −2.0 (−5–0.05) pg/mL, p = 0.001], and decreasing IL-6 [−0.67 (2.72–−0.59) vs. 0.03 (−0.59–1.84) pg/mL, p = 0.015], and MCP-1 [−29.6 (−94.9–5.50) vs. 18.3 (−97.3–66.35) pg/mL, p = 0.040]. Conclusions: A diet supplemented with marine n-3 improves inflammatory markers by increasing systemic levels of Resolvin D1 and IL-10 and decreasing IL-6 and MCP-1.

18 May 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
TSTania Sanchez-Murguia
Tania Sanchez-Murguia
NTNathaly Torres
Nathaly Torres
LMLisset Citlalic Magaña
Lisset Citlalic Magaña
SRSarai Citlalic Rodríguez-Reyes
Sarai Citlalic Rodríguez-Reyes
WPWendy Yareni Campos Pérez
Wendy Yareni Campos Pérez
EMErika Martinez-Lopez
Erika Martinez-Lopez
Appetite regulation has been recognized as a promising target for the prevention of obesity, which has become a worldwide health issue. Polymorphisms in the genes of hormones or receptors including Leu72Met for ghrelin and Gln223Arg for the leptin receptor could play a role in dietary intake, hunger, and satiety process. The aim of this study was to analyze subjective appetite assessments, dietary intake, and appetite hormones in relationship to these polymorphisms. Subjects (n = 132) with normal BMIs were enrolled. Dietary intake was analyzed with 3-day diet records. Subjective appetite was measured by visual analogue scales. Biochemical parameters were measured after 12 h of fasting and 120′ following ingestion of a test meal. Ghrelin and leptin levels were measured by ELISA assay (enzyme-linked immunosorbent assay) and insulin by chemiluminescence assay. The polymorphisms were determined by allelic discrimination using TaqMan® probes. Fasting ghrelin levels differed significantly between men and women. The consumption of fruit and bread/starch with added sugar servings, as indicated by dietary records, and measured ghrelin levels were higher in carriers of Leu72Met/Met72Met compared to Leu72Leu carriers; total sugar intake was higher in Gln223Gln carriers than in Gln223Arg/Arg223Arg carriers. In conclusion, the Leu72Met and Gln223Arg polymorphism in ghrelin and LEPR may contribute to differential responses to a standardized meal as evidenced by higher postprandial levels of ghrelin and may also contribute to a higher dietary sugar intake.

4 August 2022 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
JNJose Javier Morales Nuñez
Jose Javier Morales Nuñez
MGMariel García-Chagollán
Mariel García-Chagollán
José Francisco Muñoz-ValleJosé Francisco Muñoz-Valle
José Francisco Muñoz-Valle
SPSaúl Alberto Díaz Pérez
Saúl Alberto Díaz Pérez
Paola Carolina Torres HernándezPaola Carolina Torres Hernández
Paola Carolina Torres Hernández
JHJorge Hernández-Bello
Jorge Hernández-Bello
Purpose: Understanding the humoral immune response dynamics carried out by B cells in COVID-19 vaccination is little explored; therefore, we analyze the changes induced in the different cellular subpopulations of B cells after vaccination with BNT162b2 (Pfizer-BioNTech). Methods: This prospective cohort study evaluated thirty-nine immunized health workers (22 with prior COVID-19 and 17 without prior COVID-19) and ten subjects not vaccinated against SARS-CoV-2 (control group). B cell subpopulations (transitional, mature, naïve, memory, plasmablasts, early plasmablast, and double-negative B cells) and neutralizing antibody levels were analyzed and quantified by flow cytometry and ELISA, respectively. Results: The dynamics of the B cells subpopulations after vaccination showed the following pattern: the percentage of transitional B cells was higher in the prior COVID-19 group (p < 0.05), whereas virgin B cells were more prevalent in the group without prior COVID-19 (p < 0.05), mature B cells predominated in both vaccinated groups (p < 0.01), and memory B cells, plasmablasts, early plasmablasts, and double-negative B cells were higher in the not vaccinated group (p < 0.05). Conclusion: BNT162b2 vaccine induces changes in B cell subpopulations, especially generating plasma cells and producing neutralizing antibodies against SARS-CoV-2. However, the previous infection with SARS-CoV-2 does not significantly alter the dynamics of these subpopulations but induces more rapid and optimal antibody production.